PHFMIMethods for Predicting Heart Failure Development After Myocardial Infarction
This observational study aims to predict the development of heart failure after a myocardial infarction (heart attack) by analyzing events such as cardiovascular death, nonfatal heart attacks, any type of stroke, and hospitalization due to chronic heart failure decompensation.
Data Collection
Collected from today forward - ProspectiveCardiovascular Diseases+8
+ Heart Diseases
+ Heart Failure
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: January 1, 2019
Actual date on which the first participant was enrolled.This study is about finding ways to predict the development of heart failure after a person has had a heart attack, also known as myocardial infarction. The study is focused on patients who have been admitted to a specific hospital in Novosibirsk, Russia. The goal is to understand how heart failure develops after a heart attack, which could help doctors improve care and treatment for these patients. This research is important because heart failure is a common and serious complication after a heart attack, and being able to predict who is at risk could lead to better prevention and management strategies. During the study, patients will undergo various examinations at different points in time: on the first day of hospitalization, 30 days after the heart attack, and 12 months later. These examinations include clinical assessments, lab tests, and imaging studies like ECG and chest X-rays. Some patients may also have procedures like coronary angiography and percutaneous coronary intervention. The study will look at the results of these examinations to see if they can help predict who will develop heart failure. The primary outcome being measured is a combination of cardiovascular death, nonfatal myocardial infarction, stroke of any type, and hospitalization due to decompensation of chronic heart failure.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.186 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 70 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Novosibirsk State Medical University
Novosibirsk, RussiaOpen Novosibirsk State Medical University in Google Maps